Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Icu Medical (ICUI)
NASDAQ:ICUI
Holding ICUI?
Track your performance easily
ICUI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$83.09 - $196.26
Previous Close$167.59
Volume172.04K
Average Volume (3M)253.17K
Market Cap
$4.15B
Enterprise Value$5.75B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)―
Beta1.33
Next Earnings
Mar 04, 2025EPS Estimate
$1.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.57
Shares Outstanding24,484,266
10 Day Avg. Volume296,629
30 Day Avg. Volume253,167
Standard Deviation0.10
R-Squared0.11
Alpha-0.00199
Financial Highlights & Ratios
Price to Book (P/B)2.00
Price to Sales (P/S)1.78
Price to Cash Flow (P/CF)28.80
P/FCF Ratio17.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.46
Enterprise Value/Gross Profit7.77
Enterprise Value/Ebitda28.49
Forecast
1Y Price Target
$186.50Price Target Upside10.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
ICU Medical News
PremiumCompany Announcements
ICU Medical Reports Q3 2024 Financial Results
Bulls Say, Bears Say
Bulls Say
Financial PerformanceICUI's 3Q24 revenue, EBITDA, and EPS beat consensus.
Market PositionICUI holds a leading position in the growing market for IV equipment and disposables.
Strategic PartnershipsICUI announced an IV Solutions joint venture with Otsuka and will transfer its IV solutions plant into the JV.
Bears Say
Market ShareProprietary survey and channel checks suggest ICUI is unlikely to take material market share from competitors BDX or BAX.
Revenue GrowthRevenue growth slowed to 7% CC in 3Q24 from 10% CC in 2Q24.
Stock ValuationICUI shares are trading at a premium with limited upside potential to consensus estimates for the years 2024 to 2026.
---
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
ICUI FAQ
What was Icu Medical’s price range in the past 12 months?
Icu Medical lowest stock price was $83.09 and its highest was $196.26 in the past 12 months.
What is Icu Medical’s market cap?
Currently, no data Available
When is Icu Medical’s upcoming earnings report date?
Icu Medical’s upcoming earnings report date is Mar 04, 2025 which is in 103 days.
How were Icu Medical’s earnings last quarter?
Icu Medical released its earnings results on Nov 12, 2024. The company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.25 by $0.34.
Is Icu Medical overvalued?
According to Wall Street analysts Icu Medical’s price is currently Undervalued.
Does Icu Medical pay dividends?
Icu Medical does not currently pay dividends.
What is Icu Medical’s EPS estimate?
Icu Medical’s EPS estimate is $1.49.
How many shares outstanding does Icu Medical have?
Icu Medical has 24,484,266 shares outstanding.
What happened to Icu Medical’s price movement after its last earnings report?
Icu Medical reported an EPS of $1.59 in its last earnings report, beating expectations of $1.25. Following the earnings report the stock price went down -1.798%.
Which hedge fund is a major shareholder of Icu Medical?
Among the largest hedge funds holding Icu Medical’s share is Woodline Partners LP. It holds Icu Medical’s shares valued at 21M.
---
ICU Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$186.50 (10.46% Upside)
$186.50 (10.46% Upside)
Hedge Fund Trend
Decreased
By 36.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $408.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.8%
Last 30 Days ▲ 29.0%
Last 30 Days ▲ 29.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
94.12%
12-Months-Change
Fundamentals
Return on Equity
-5.35%
Trailing 12-Months
Asset Growth
-1.64%
Trailing 12-Months
Company Description
Icu Medical
ICU Medical, Inc. is an infusion therapy company, which engages in the development, manufacturing and sale of innovative medical devices used in vascular therapy and critical care applications. The company's product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors designed to help meet clinical, safety and workflow goals. Its customers are acute care hospitals, wholesalers, ambulatory clinics and alternate site facilities, such as clinics, home health care providers and long-term care facilities. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
---
ICUI Company Deck
---
ICUI Earnings Call
Q3 2024
0:00 / 0:00
---
ICUI Stock 12 Month Forecast
Average Price Target
$186.50
▲(10.46% Upside)
Technical Analysis
Best Analysts Covering ICUI
1 Year
1 Year Success Rate
24/38 ratings generated profit
1 Year Average Return
+10.58%
reiterated a buy rating 2 months ago
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 63.16% of your transactions generating a profit, with an average return of +10.58% per trade.
---